NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
Back to search
Official data from USPTO
CANCERVISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANCERVISION
ST13
US500000097414523Class
42, 44
Filing
97414523
Registration
8196483
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/31/2026
Trademark type
Word
Nice classes
42, 44
Filing date
05/17/2022
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/22/2024
First use in commerce
03/22/2024
Drawing code
4
Owner type
03
Owner location
SAN DIEGO, CA, US
Examiner
GOODWIN, KATRINA JOYE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
INOCRAS INC.
GENOME INSIGHT, INC.
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Consultancy relating to research in the field of pharmacogenetics; scientific laboratory services namelysolvent testing services; scientific research in the field of genetic engineering; laboratory research in the field of gene expression; scientific research namelyresearch in the field of gene analysis; genetic testing for scientific research purposes namelygenetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; scientific research namelygenetic research; genetic testing for scientific research purposes; scientific research; web site design; creating and designing website-based indexes of information for others using information technology; product research namelyresearch into new products; provision of internet search engines; database development services; developmentprogrammingimplementation of software for others; scientific research namelyresearch and testing services in the fields of bacteriology and virology; remote monitoring of medical data for medical diagnosis namelytechnical and scientific monitoring services relating to medical diagnostic instruments; structural and functional analysis of genomes
Class 44
Medical and pharmaceutical consultation namelyconsultancy and information services relating to biopharmaceutical products; medical services namelymedical and health services relating to DNAgenetics and genetic testing; genetic testing for medical purposes; medical services namelyprovision of genetic information for medical treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; psychological consultation; beauty consultation services in the selection and use of cosmetics; consultancy services relating to beauty; providing information about beauty; health spa services namelycosmetic body care services; pharmaceutical advice; medical services namelyanalysis of human biodata for medical purposes; medical services namelyprovision of genetic testing for medical treatment purposes; medical services namelyprovision of gene therapy for medical treatment purposes
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/09/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/09/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/09/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/09/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/09/2026
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
03/09/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/23/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/23/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/02/2025
IUAF
USE AMENDMENT FILED
06/23/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/23/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/25/2025
PUBO
PUBLISHED FOR OPPOSITION
03/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/14/2024
GNRT
NON-FINAL ACTION E-MAILED
11/14/2024
CNRT
NON-FINAL ACTION WRITTEN
11/14/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/16/2024
DOCK
ASSIGNED TO EXAMINER
02/15/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/05/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/11/2023
GNSL
LETTER OF SUSPENSION E-MAILED
05/11/2023
CNSL
SUSPENSION LETTER WRITTEN
05/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2023
GNRT
NON-FINAL ACTION E-MAILED
03/13/2023
CNRT
NON-FINAL ACTION WRITTEN
03/13/2023
DOCK
ASSIGNED TO EXAMINER
03/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2022
NWAP
NEW APPLICATION ENTERED
05/20/2022
Continuous trademark protection
Get notified about every new filing that threatens CANCERVISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.